 |
|
dexverapamil
The R-enantiomer of the calcium channel blocker verapamil. Dexverapamil competitively inhibits the multidrug resistance efflux pump P-glycoprotein (MDR-1), thereby potentially increasing the effectiveness of a wide range of antineoplastic drugs which are inactivated by MDR-1 mechanisms. This agent exhibits decreased calcium antagonistic activity and toxicity compared to racemic verapamil. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | R verapamil
R-verapamil
R-Verapamil Hydrochloride | | |
|
|
